S18-498 Combination of differentiation therapy and metabolic intervention to treat neuroblastoma Researchers at Stanford have developed a combination therapy to treat neuroblastoma, the most common and deadly solid tumor in childhood. Neuroblastoma derives from neural crest cells that fail to exit the cell cycle and differentiate. Jiangbin Ye Yang Li